High materiality8/10
Ultragenyx Pharma (RARE) PT Raised to $39 at Canaccord
Why it may matterVerify against the original reporting
Upside potential implied by a higher target.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Canaccord Genuity raises Ultragenyx Pharma price target to $39; current price around $14.50.
- Canaccord Genuity raises RARE PT to $39; current price $14.50.
Key facts
- 01
Target: $39
- 02
Posted price: $14.5
- 03
Analyst firm: Canaccord Genuity
- 04
Analyst: Whitney Ijem
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.